Atlas Trials

Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes

Clinical trial NCT02518945 · COMPLETED

Trial details

NCT number
NCT02518945
Sponsor
University at Buffalo
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2015-08-01
Primary completion
2015-12-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.